The Stamp of Approval On-going Growth
The Stamp of Approval
Precision Metal Pressings / Precision Metal Stampings
Embodying seven decades of proven industry experience, Clamason Industries Ltd. represents Europe’s leading manufacturer of precision metal pressings / precision metal stampings. With a turnover well in excess of £20 million, and recorded annual growth of 18 per cent between 2015 and 2016, Clamason Industries Ltd. (Clamason) has developed an enviable reputation within the global manufacturing and export markets. The rich history of the company as a leading manufacturer of components in precision pressings and stampings dates back to the formation of the firm in Kingswinford, West Midlands in 1947.
The business originally specialised in the development of small and complex parts, which utilised both multi-slide and low tonnage high speed presses. Each of these capabilities remain core competencies within the business, which has since evolved to hold manufacturing facilities within the UK and Slovakia. Clamason today produces precision metal pressings / precision metal stampings that are employed across several automotive, medical and industrial applications.
The company reached an important milestone during December 2016, when it was announced that its management had completed a buyout of Clamason with assistance from Connection Capital. The new business structure will allow Clamason to make longer-term investment decisions, while the deal has also provided capital for the on-going growth of both the company’s UK and Slovak precision metal pressing / precision metal stamping manufacturing facilities.
An important element of the MBO was a focus on protecting the values that had been instilled within the business throughout the course of seven decades of family ownership. “We possess a wealth of experience, more than 1500 years in the UK team alone with 35per cent of employees having ten plus years of service, this gives us a massive advantage when it comes to solving complex problems and overcoming challenges when executing projects,” Neil continues. “We also have a very collaborative culture, one that is displayed in the cross-table discussions that regularly occur in which we pull together the thoughts and opinions of all of our key staff.”
Clamason is equally as keen to mould the talents of the next generation of employees, with ten apprentices currently going through the business. “Our apprenticeship schemes are all locally generated and form a key part of a layered approach to business continuity, the intention of which is to think ahead in order to secure the future growth of Clamason and its people,” states Sales Director, Ian Davies.
The company can list a number of blue chip clients, including the likes of Bosch, Delphi, Visteon, Sanofi, Schneider Electric and Siemens, who aresupplied with components that originate from Clamason’s 60-plus precision metal pressing / precision metal stamping machines located at its 6600 square metre Kingswinford facility and its 2700 square metre site in Slovakia. The latter facility will be undergoing an extension to 4700 square metres in July 2017 in response to increasing customer demand. Clamason are also considering another European manufacturing location to support several of its key customers.
Throughout its history Clamason has made significant investment in its precision metal pressing / precision metal stamping production capabilities, the purchase of larger stamping presses, andthe development of advanced welding and automation. This has enabled the company to target the expanding markets in the fields of automotive safety and electronics. Applications within these sectors include the developmentof complex stampings for airbags, enginecontrol units, in-car entertainment systems and driverless technology, which is an increasingly important area of growth. In addition, Clamason also took the decision to invest in smaller high speed Bruderer presses and now manufactures more than 350 million components per annum for medical devices. To support its customers, Clamason has BS ISO 9001, ISO/TS16949, ISO14001 and BS13485 accreditations, and is certified to FDA CFR21 Parts 820, the US standard for metal stampings for medical device, and is one of the only stampers in Europe to be compliant to this standard.
As Neil correctly highlights, we live in a world where today much of what takes place in the manufacturing industry is defined by the carbon footprint that it subsequently creates. While a number of traditional manufacturing techniques, such as extruding and casting, are becoming less sustainable, stamped metal products provided by Clamason can be recycled multiple times, making them a light touch when it comes to environmental impact.
In addition to being increasingly focused on the concept of sustainability, the market that Clamason finds itself in today has a particular ‘wait and see’ mind-set. This is especially prevalent in the UK in light of the vote to leave the European Union in 2016 and the ongoing Brexit negotiations. Despite this fact, the company finds itself well placed to counteract any potential downturns. “We are a pan-European business in that we buy from the UK and mainland Europe, and sell to blue chip companies in Germany, France and beyond,” Ian details. “While these companies do have alternative suppliers that they can turn to, the value that we create for them is significant enough for them to continue to partner with us.”
Stable and profitable, Clamason expects to achieve further growth of around 18 per cent for the year 2016-2017. “This is a market that is in constant need for innovation and being at the cutting edge of design, productivity and automation, has gone hand-in-hand with our ability to deliver quality products in short timeframes,” Neil concludes. “It is this level of service that continues to strengthen our customer relationships.”
- Date: Wednesday December 12th, 2018